Sign In
Buy LABU
$165.45
+7.29 (+4.61%)
At Close: Jun 03, 2026
Biotech Bounces in August as M&A Activity Increases
02:55pm, Monday, 22'nd Aug 2022
The biotech sector deflated, as most sectors did, in the first half of 2022. However, the sector is in the midst of a comeback as mergers and acquisitions rise, signaling increased activity.
LABU Continues In Uptrend (Technical Analysis)
06:41am, Friday, 12'th Aug 2022
During July, LABU traded in a narrow range. In August, its uptrend has resumed. We expect that LABU's uptrend has a long way to go.
Top Performing Leveraged/Inverse ETFs: 08/07/2022
04:19pm, Tuesday, 09'th Aug 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Best Inverse/Leveraged ETFs of Last Week
12:00pm, Monday, 08'th Aug 2022 Zacks Investment Research
Wall Street was moderate last week. oil prices too faded lately.
Best Inverse/Leveraged ETFs of Last Week
09:02am, Monday, 08'th Aug 2022
Wall Street was moderate last week. oil prices too faded lately.
LABU And The Biotechs Look Ready To Outperform (Technical Analysis)
06:14am, Friday, 05'th Aug 2022
I believe small- and mid-cap biotech bottomed in May through June and has outperformed the broader market since then. Biotech continues to show strong relative outperformance versus the market and mos
Investors piling into healthcare ETFs points to defensive bets, ‘bottom-fishing’ in biotech
07:52pm, Thursday, 14'th Jul 2022 MarketWatch
In this week's ETF Wrap, healthcare ETFs take the spotlight as investors get defensive amid recession fears. But inflows also show that some investors may be “bottom-fishing” for beaten down stock
Biotech Sector Is Garnering Interest From Investors Again
02:06pm, Thursday, 14'th Jul 2022
The biotech sector has been rallying as of late, evidenced by the S&P 500 Biotechnology Index up close to 9% within the past month. Of course, as we've seen so far in 2022, rallies are difficult to su
Top Performing Leveraged/Inverse ETFs: 07/10/2022
02:04pm, Tuesday, 12'th Jul 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Leveraged Biotech ETFs: Buy LABU, Sell LABD
09:00am, Friday, 08'th Jul 2022
Starting with September 2021, LABU had a record sequence of nine consecutive months with negative returns. During the biotech downtrend from September 2021 to April 2022, LABD has returned 207%.
Top Performing Leveraged/Inverse ETFs: 06/26/2022
02:29pm, Wednesday, 29'th Jun 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
The Zacks Analyst Blog Highlights LABU, WEBL, and KOLD
02:40pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
LABU, WEBL, and KOLD are part of Zacks top Analyst Blog.
S&P 500's Second-Best Week in 2022: Best Leveraged ETFs
12:00pm, Monday, 27'th Jun 2022 Zacks Investment Research
U.S. stocks saw a massive jump on the final trading session of last week, making the week successful one.
S&P 500's Second-Best Week in 2022: Best Leveraged ETFs
09:14am, Monday, 27'th Jun 2022
U.S. stocks saw a massive jump on the final trading session of last week, making the week successful one.
LABU: This 3X Leveraged Bull ETF Fails To Raise Any Optimism
07:28am, Thursday, 23'rd Jun 2022
Since my last coverage in the previous quarter, LABU has been on a free fall for the past 12 weeks and also recorded a huge loss over the past 6. 3X funds like LABU have the highest expense ratio and�
